Compare ASRT & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASRT | LFT |
|---|---|---|
| Founded | 1995 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.0M | 68.1M |
| IPO Year | 2004 | N/A |
| Metric | ASRT | LFT |
|---|---|---|
| Price | $18.04 | $1.29 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 216.9K | 137.9K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 17.05% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $118,713,000.00 | N/A |
| Revenue This Year | N/A | $668.15 |
| Revenue Next Year | $16.61 | N/A |
| P/E Ratio | ★ N/A | $13.49 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.57 | $1.18 |
| 52 Week High | $20.45 | $2.71 |
| Indicator | ASRT | LFT |
|---|---|---|
| Relative Strength Index (RSI) | 63.65 | 48.50 |
| Support Level | $0.70 | $1.26 |
| Resistance Level | $20.45 | $1.43 |
| Average True Range (ATR) | 1.01 | 0.07 |
| MACD | -0.23 | 0.01 |
| Stochastic Oscillator | 37.03 | 67.86 |
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.